Characterization of the antiviral and nuclear regulatory functions of FEZ1 & NEK1

FEZ1 抗病毒和核调节功能的表征

基本信息

项目摘要

DESCRIPTION (provided by applicant): Human immunodeficiency virus type 1 (HIV-1) is a member of the retroviridae that causes Acquired Immunodeficiency Syndome (AIDS), which affects over 33.3 million people worldwide. Like many viruses, retroviruses require access to the host nucleus in order to replicate yet the processes and factors involved remain poorly understood. After entry into the cell, viral particles transit the cytoplasm to the nucleus on host microtubules, long filamentous transport networks that arrange around the microtubule organizing centre (MTOC) located near the nucleus. Our recent work has identified a neuronal protein, FEZ1 that localizes to the MTOC and suppress infection by a number of retroviruses, including HIV-1, by blocking the entry of viral DNA into the nucleus. Our preliminary data also suggests that the FEZ1 interacting protein, NEK1 has a similar neuronal expression pattern and inhibitory effect on HIV-1 infection, suggesting that FEZ1 and at least some of its interacting proteins may form part of a neuronal complex that impairs retroviral infection. Our additional preliminary data shows that FEZ1 also suppresses infection by another clinically important neurotropic DNA virus, Herpes Simplex Virus type 1 (HSV-1), suggesting that FEZ1 expression in neurons may limit their susceptibility to infection by a number of distinct viruses. Finally, ectopic expression of FEZ1 in microglia, another brain cell type, causes changes in nuclear architecture, called multi-lobulation, which may contribute to its antiviral properties and which suggests that FEZ1 and its interacting proteins may regulate important, poorly understood functions of the nucleus itself. In this proposal, we aim to characterize the antiviral and nuclear regulatory functions of FEZ1 in detail, defining the domains involved in regulating infection as well as those involved in the formation of multi-lobulated nuclei, and determining the regulation of FEZ1 function by host signaling pathways. By also examining the contribution of additional FEZ1- and NEK1-interacting factors to the phenotypes observed, we hope to build a picture of how these proteins regulate viral infection and nuclear architecture or movement, which will provide important insights into how factors associated with the MTOC communicate with and regulate nuclear functions important for viral infection and the broader movement of large cargoes, such as viral capsids, into the nucleus. As such, these studies are also likely to contribute to our broader understanding of the control of nuclear transport and architecture. PUBLIC HEALTH RELEVANCE: HIV-1 infects 33.3 million people worldwide while HSV-1 has established lifelong infections in an estimated 80% of the world population, causing periodic cold sores, corneal blindness and encephalitis. Understanding how FEZ1/NEK1 inhibits these viruses could identify important new avenues for therapeutic intervention.
描述(申请人提供):人类免疫缺陷病毒1型(HIV-1)是引起获得性免疫缺陷综合征(AIDS)的逆转录病毒科的成员,全球有3330多万人受到影响。像许多病毒一样,逆转录病毒需要进入宿主细胞核才能复制,但所涉及的过程和因素仍然知之甚少。进入细胞后,病毒颗粒通过细胞质到达宿主的细胞核。 微管,围绕位于细胞核附近的微管组织中心(MTOC)排列的长丝状运输网络。我们最近的工作发现了一种神经元蛋白FEZ1,它定位于MTOC,通过阻止病毒DNA进入细胞核来抑制包括HIV-1在内的许多逆转录病毒的感染。我们的初步数据还表明,FEZ1相互作用蛋白NEK1具有类似的神经元表达模式和对HIV-1感染的抑制作用,这表明FEZ1及其至少部分相互作用蛋白可能形成了损害逆转录病毒感染的神经元复合体的一部分。我们的其他初步数据显示,FEZ1还抑制了另一种临床上重要的嗜神经性DNA病毒-1型单纯疱疹病毒(HSV-1)的感染,这表明FEZ1在神经元中的表达可能限制了它们对多种不同病毒感染的敏感性。最后,FEZ1在另一种脑细胞类型小胶质细胞中的异位表达导致核结构的变化,称为多分叶,这可能有助于其抗病毒特性,这表明FEZ1及其相互作用的蛋白可能调节核本身的重要功能,这些功能知之甚少。在这项提案中,我们的目标是表征抗病毒和核 详细介绍了FEZ1的调控功能,定义了参与调控感染的结构域以及参与形成多叶状核的结构域,并确定了宿主信号通路对FEZ1功能的调控。通过研究额外的FEZ1和NEK1相互作用因子对观察到的表型的贡献,我们希望建立一幅这些蛋白质如何调控病毒感染和核结构或运动的图景,这将为与MTOC相关的因子如何与病毒感染和更广泛的大型货物(如病毒衣壳)进入细胞核的运动有关的核功能的沟通和调控提供重要的见解。因此,这些研究也可能有助于我们更广泛地了解核运输和建筑的控制。 公共卫生相关性:艾滋病毒-1感染了全世界3330万人,而单纯疱疹病毒-1已在估计80%的世界人口中建立了终身感染,导致周期性冻疮、角膜失明和脑炎。了解FEZ1/NEK1如何抑制这些病毒可以确定治疗干预的重要新途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mojgan Hosseini Naghavi其他文献

Mojgan Hosseini Naghavi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mojgan Hosseini Naghavi', 18)}}的其他基金

+TIPs as novel host capsid-binding co-factors in early HIV-1 infection
TIP 作为早期 HIV-1 感染中新型宿主衣壳结合辅助因子
  • 批准号:
    10709142
  • 财政年份:
    2023
  • 资助金额:
    $ 30.4万
  • 项目类别:
The role of amyloid precursor protein in HIV-1 replication and associated neurodegeneration
淀粉样前体蛋白在 HIV-1 复制和相关神经变性中的作用
  • 批准号:
    9348763
  • 财政年份:
    2017
  • 资助金额:
    $ 30.4万
  • 项目类别:
The role of FEZ1 in early HIV-1 infection
FEZ1 在早期 HIV-1 感染中的作用
  • 批准号:
    10207439
  • 财政年份:
    2012
  • 资助金额:
    $ 30.4万
  • 项目类别:
Characterization of the antiviral and nuclear regulatory functions of FEZ1 & NEK1
FEZ1 抗病毒和核调节功能的表征
  • 批准号:
    8930337
  • 财政年份:
    2012
  • 资助金额:
    $ 30.4万
  • 项目类别:
The role of FEZ1 in early HIV-1 infection
FEZ1 在早期 HIV-1 感染中的作用
  • 批准号:
    9980793
  • 财政年份:
    2012
  • 资助金额:
    $ 30.4万
  • 项目类别:
Characterization of the antiviral and nuclear regulatory functions of FEZ1 & NEK1
FEZ1 抗病毒和核调节功能的表征
  • 批准号:
    8550105
  • 财政年份:
    2012
  • 资助金额:
    $ 30.4万
  • 项目类别:
The role of FEZ1 in early HIV-1 infection
FEZ1 在早期 HIV-1 感染中的作用
  • 批准号:
    10647657
  • 财政年份:
    2012
  • 资助金额:
    $ 30.4万
  • 项目类别:
Characterization of the antiviral and nuclear regulatory functions of FEZ1 & NEK1
FEZ1 抗病毒和核调节功能的表征
  • 批准号:
    8706187
  • 财政年份:
    2012
  • 资助金额:
    $ 30.4万
  • 项目类别:
The role of FEZ1 in early HIV-1 infection
FEZ1 在早期 HIV-1 感染中的作用
  • 批准号:
    10438790
  • 财政年份:
    2012
  • 资助金额:
    $ 30.4万
  • 项目类别:

相似海外基金

Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
  • 批准号:
    23K18186
  • 财政年份:
    2023
  • 资助金额:
    $ 30.4万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
  • 批准号:
    10560883
  • 财政年份:
    2023
  • 资助金额:
    $ 30.4万
  • 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10730692
  • 财政年份:
    2021
  • 资助金额:
    $ 30.4万
  • 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
  • 批准号:
    21K06459
  • 财政年份:
    2021
  • 资助金额:
    $ 30.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10189880
  • 财政年份:
    2021
  • 资助金额:
    $ 30.4万
  • 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
  • 批准号:
    2404261
  • 财政年份:
    2020
  • 资助金额:
    $ 30.4万
  • 项目类别:
    Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10222540
  • 财政年份:
    2020
  • 资助金额:
    $ 30.4万
  • 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10669717
  • 财政年份:
    2020
  • 资助金额:
    $ 30.4万
  • 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
  • 批准号:
    20K10713
  • 财政年份:
    2020
  • 资助金额:
    $ 30.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10174522
  • 财政年份:
    2020
  • 资助金额:
    $ 30.4万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了